Minirin Melt (Desmopressin)

Desmopressin, the active ingredient in Minirin Melt, is a vasopressin analog presented as a sublingual melt tablet for sublingual use. It treats central diabetes insipidus, primary nocturnal enuresis, and certain bleeding disorders such as mild hemophilia A and von Willebrand disease.

GNH USA supplies Minirin Melt as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across markets.

Desmopressin is used to manage conditions that involve deficient antidiuretic hormone activity or impaired clotting. - Central diabetes insipidus: reduces excessive urine output by enhancing water reabsorption. - Primary nocturnal enuresis: decreases nighttime bedwetting episodes in children by concentrating urine. - Bleeding disorders (e.g., mild hemophilia A, von Willebrand disease): raises plasma levels of factor VIII and von Willebrand factor to improve hemostasis.

Desmopressin may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache: mild to moderate pain in the head. - Nasal congestion: sensation of a blocked nose. - Nausea: feeling of stomach upset. - Hyponatremia: low blood sodium, usually mild.

Serious or Rare Side Effects: - Severe hyponatremia with seizures: marked drop in sodium leading to neurological symptoms. - Water intoxication: excessive water retention causing edema. - Allergic reaction: rash, itching, or swelling. - Thrombotic events: rare clot formation in susceptible patients.

When prescribing desmopressin, clinicians should consider several safety precautions. - Fluid restriction: limit excessive fluid intake to reduce risk of hyponatremia. - Monitor electrolytes: check serum sodium regularly, especially in the elderly or renal impairment. - Cardiovascular disease: use cautiously in patients with heart failure or hypertension. - Pregnancy: avoid unless benefits outweigh risks, as safety data are limited. - Concomitant hyponatremic drugs: avoid combining with other agents that lower sodium (e.g., thiazides). - Store at ambient temperature: keep below 25 °C in the original packaging, protected from moisture.

Desmopressin can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: increases metabolism of desmopressin, reducing effect. - Phenytoin: enzyme induction leading to decreased antidiuretic action. - High‑dose NSAIDs: may potentiate antidiuretic effect and increase hyponatremia risk.

Moderate Interactions (Monitor Closely): - Diuretics (especially thiazides): additive effect on water retention and sodium loss. - SSRIs and SNRIs: may increase risk of hyponatremia. - Hormonal contraceptives: can enhance antidiuretic response. - ACE inhibitors/ARBs: may augment water retention, requiring monitoring.